Pfizer, known for its pandemic vaccine, adapted to falling post-pandemic demand by investing $43 billion into Seagen, enhancing revenue through quality cancer products.
Having just reported $13.3 billion in revenue with a 3% increase, Pfizer anticipates revenues between $59.5 billion and $62.5 billion, reinforcing its growth strategies.
Diversifying its portfolio, Pfizer shows resilience by issuing a consistent dividend yield of 5.84%, highlighting its appeal for long-term and dividend-focused investors.
Trading at $28, PFE has faced challenges with a 3% drop YTD and 21% decline over the past year, underscoring the importance of strategic investments.
[
Collection
]
[
|
...
]